'Useless drugs' prof doubts pace of French reform
This article was originally published in Scrip
Executive Summary
The French academic behind the best-selling "Guide to the 4,000 useful, useless or dangerous medicines" has conceded that the regulatory process in France is improving but warned that progress may be slower than most people would want.